GeneFerm Biotechnology Co., Ltd. announced earnings results for the full year ended December 31, 2019. For the full year, the company announced sales was TWD 328.230 million compared to TWD 357.447 million a year ago. Operating loss was TWD 23.378 million compared to operating Income of TWD 9.358 million a year ago. Net loss was TWD 27.550 million compared to net income of TWD 10.315 million a year ago. Basic loss per share was TWD 0.99 compared to basic earnings per share of TWD 0.38 a year ago. Diluted loss per share was TWD 0.99 compared to diluted earnings per share of TWD 0.37 a year ago.